Lincoln National Has Boosted Exxon Mobil (XOM) Stake By $425,817; Acceleron Pharma (XLRN)’s Sentiment Is 1.81

January 14, 2018 - By Linda Rogers

Lincoln National Corp increased Exxon Mobil Corp (XOM) stake by 8.69% reported in 2017Q3 SEC filing. Lincoln National Corp acquired 5,257 shares as Exxon Mobil Corp (XOM)’s stock rose 0.21%. The Lincoln National Corp holds 65,760 shares with $5.39 million value, up from 60,503 last quarter. Exxon Mobil Corp now has $370.83B valuation. The stock increased 0.68% or $0.59 during the last trading session, reaching $87.52. About 9.83M shares traded. Exxon Mobil Corporation (NYSE:XOM) has declined 9.08% since January 14, 2017 and is downtrending. It has underperformed by 25.78% the S&P500.

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for serious and rare diseases. The company has market cap of $2.04 billion. The Company’s therapeutic candidates include luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassemia; and sotatercept for chronic kidney diseases. It currently has negative earnings. The companyÂ’s therapeutic candidates also include dalantercept, a tyrosine kinase inhibitor, which is in phase II clinical trials for renal cell carcinoma; and ACE-083 that is in phase II clinical trials for facioscapulohumeral dystrophy.

Among 26 analysts covering Exxon Mobil (NYSE:XOM), 10 have Buy rating, 6 Sell and 10 Hold. Therefore 38% are positive. Exxon Mobil had 80 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by UBS on Monday, May 2 with “Neutral”. The firm earned “Hold” rating on Thursday, October 19 by Jefferies. The stock of Exxon Mobil Corporation (NYSE:XOM) has “Hold” rating given on Tuesday, August 29 by Jefferies. As per Monday, June 5, the company rating was upgraded by Howard Weil. The stock has “Hold” rating by HSBC on Wednesday, March 8. The rating was downgraded by Bank of America on Thursday, June 2 to “Neutral”. On Thursday, July 27 the stock rating was maintained by Jefferies with “Hold”. The firm has “Neutral” rating given on Monday, October 31 by Goldman Sachs. The firm has “Buy” rating by Cowen & Co given on Tuesday, October 24. As per Thursday, August 6, the company rating was maintained by TD Securities.

Investors sentiment is 0.85 in 2017 Q3. Its the same as in 2017Q2. It is flat, as 57 investors sold XOM shares while 806 reduced holdings. only 114 funds opened positions while 621 raised stakes. 2.13 billion shares or 0.48% more from 2.12 billion shares in 2017Q2 were reported. Wilbanks Smith And Thomas Asset Management Limited Liability has 89,358 shares. Retirement Of Alabama owns 3.09M shares for 1.32% of their portfolio. 50,397 are owned by Van Eck Associates. Fairview Capital Invest Mngmt Ltd Company invested in 0.21% or 40,411 shares. Brandywine Trust Company accumulated 165,066 shares or 12.11% of the stock. North Point Managers Corp Oh invested in 1.97% or 142,344 shares. Wellington Shields Ltd Co invested in 46,517 shares or 1.26% of the stock. Yacktman Asset Lp stated it has 1.94% in Exxon Mobil Corporation (NYSE:XOM). Ballentine Ltd reported 38,032 shares or 0.17% of all its holdings. Hayek Kallen Investment Management accumulated 3.47% or 61,797 shares. Sarl owns 0.49% invested in Exxon Mobil Corporation (NYSE:XOM) for 72,600 shares. Bell Commercial Bank invested in 1.19% or 49,997 shares. Adirondack Tru Co invested in 33,420 shares. Tennessee-based Aldebaran has invested 2.62% in Exxon Mobil Corporation (NYSE:XOM). Grisanti Cap Management Llc holds 0.17% of its portfolio in Exxon Mobil Corporation (NYSE:XOM) for 4,937 shares.

Since August 4, 2017, it had 0 insider purchases, and 6 selling transactions for $5.32 million activity. $88,253 worth of Exxon Mobil Corporation (NYSE:XOM) was sold by REINEMUND STEVEN. $200,293 worth of Exxon Mobil Corporation (NYSE:XOM) was sold by Wascom Dennis G. 12,000 shares valued at $996,628 were sold by Chapman Neil A on Thursday, December 14. $1.62M worth of Exxon Mobil Corporation (NYSE:XOM) was sold by Corson Bradley W. Milton Bryan W had sold 7,281 shares worth $606,082. 22,656 shares were sold by Franklin Robert Stuart, worth $1.81M on Monday, September 18.

The stock increased 2.76% or $1.21 during the last trading session, reaching $45.12. About 666,831 shares traded or 114.63% up from the average. Acceleron Pharma Inc. (XLRN) has declined 22.43% since January 14, 2017 and is downtrending. It has underperformed by 39.13% the S&P500.

Since January 1, 0001, it had 1 insider buy, and 12 selling transactions for $19.64 million activity.

Analysts await Acceleron Pharma Inc. (NASDAQ:XLRN) to report earnings on March, 7. They expect $-0.60 EPS, down 17.65% or $0.09 from last year’s $-0.51 per share. After $-0.65 actual EPS reported by Acceleron Pharma Inc. for the previous quarter, Wall Street now forecasts -7.69% EPS growth.

Foresite Capital Management Ii Llc holds 3.7% of its portfolio in Acceleron Pharma Inc. for 244,756 shares. Sectoral Asset Management Inc owns 604,957 shares or 2.91% of their US portfolio. Moreover, Ghost Tree Capital Llc has 2.77% invested in the company for 350,000 shares. The New York-based Perceptive Advisors Llc has invested 2.3% in the stock. Hamilton Lane Advisors Llc, a Pennsylvania-based fund reported 74,990 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>